Xiu-wu F. Pan

1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications

Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial.

Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial.

Journal: European urology
Published: April 10, 2026

Correction: Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma.

Correction: Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma.

Journal: Cell death & disease
Published: March 25, 2026

Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.

Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.

Journal: European urology
Published: March 11, 2026

Re: HIF-2-dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma.

Re: HIF-2-dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma.

Journal: European urology
Published: February 08, 2026

SH3BGRL3 is a pancancer prognostic and immunological biomarker.

SH3BGRL3 is a pancancer prognostic and immunological biomarker.

Journal: Discover oncology
Published: January 21, 2026

Re: Soluble MAdCAM-1 as a Biomarker in Metastatic Renal Cell Carcinoma.

Re: Soluble MAdCAM-1 as a Biomarker in Metastatic Renal Cell Carcinoma.

Journal: European urology
Published: January 20, 2026

Re: Targeting of HIF2-driven Cachexia in Kidney Cancer.

Re: Targeting of HIF2-driven Cachexia in Kidney Cancer.

Journal: European urology
Published: January 03, 2026

Celastrol induces ferroptosis in ccRCC through TEF-Driven ACOX2 upregulation and metabolic reprogramming.

Celastrol induces ferroptosis in ccRCC through TEF-Driven ACOX2 upregulation and metabolic reprogramming.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 10, 2025

Comprehensive analysis of the causal risk factor from hypertension associated with prognosis and therapeutic response in renal cell carcinoma by multi-omics analysis and validation.

Comprehensive analysis of the causal risk factor from hypertension associated with prognosis and therapeutic response in renal cell carcinoma by multi-omics analysis and validation.

Journal: Biology direct
Published: November 26, 2025

Re: ACOX2 Destabilizes the MRE11-RAD50-NBS1 Complex and Boosts Anticancer Immunity via the cGAS-STING Pathway in Clear Cell Renal Cell Carcinoma.

Re: ACOX2 Destabilizes the MRE11-RAD50-NBS1 Complex and Boosts Anticancer Immunity via the cGAS-STING Pathway in Clear Cell Renal Cell Carcinoma.

Journal: European urology
Published: November 04, 2025

Application of Ultra Micro Angiography in Differential Diagnosis of Renal Tumors.

Application of Ultra Micro Angiography in Differential Diagnosis of Renal Tumors.

Journal: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Published: September 11, 2025

Re: Comprehensive Tumor-immune Profiling Reveals Mediators of Paradoxical Immune Sensitivity in Sarcomatoid Renal Cell Carcinoma.

Re: Comprehensive Tumor-immune Profiling Reveals Mediators of Paradoxical Immune Sensitivity in Sarcomatoid Renal Cell Carcinoma.

Journal: European urology
Published: August 15, 2025
Showing 1-12 of 69

Last Updated: 09/26/2026